Clinical Trial: Clinical Study of Adebrelimab Therapy in the Perioperative Treatment of Gastric Cancer or Gastroesophageal Junction Cancer

U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07522151) titled 'Clinical Study of Adebrelimab Therapy in the Perioperative Treatment of Gastric Cancer or Gastroesophageal Junction Cancer' on April 03.

Brief Summary: This study was a randomized, double-blind, multi-center phase III clinical trial to evaluate the event-free survival (EFS) of Adebrelimab with S-1 and oxaliplatin versus placebo combined with S-1 and oxaliplatin, and to evaluate the efficacy, safety and tolerability of the two combination regimens.

Study Start Date: May, 2026

Study Type: INTERVENTIONAL

Condition: Locally Advanced Gastric or Gastroesophageal Junction Cancer

Intervention: DRUG: Adebrelimab plus S-1 and oxaliplat...